AI in Healthcare Today - September 17, 2026

The latest in ai in healthcare: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: ByteDance AI drug discovery spin-off Anew Labs raises $290M at $1.5B valuation.

ByteDance AI drug discovery spin-off Anew Labs raises $290M at $1.5B valuation

TNGlobal2026-09-17

Is the pharmaceutical industry ushering in a new narrative? Industry giants are collectively pivoting to AI4S, with high‑profile collaborations at home and abroad and the commercialization of cutting‑edge technologies driving momentum. The AI‑driven drug disc

富途牛牛2026-09-17

Is the pharmaceutical industry embracing a new narrative? Industry giants are collectively pivoting toward AI for Science (AI4S), catalyzed by major domestic and international collaborations and technological implementation, marking a critical phase for value r

Moomoo2026-09-17

AI Drug Discovery Demand Surges: Synthetic Biology Leader Expects Orders to Double to $100 Million Next Year

finance.biggo.com2026-09-17

Anthropic's Drug Discovery Partners: AI Pharmaceutical Orders Set to Double Next Year

36 Kr2026-09-17

ByteDance's Anew Labs reportedly raises US$290M as AI drug discovery gains momentum

digitimes.com2026-09-17

Follow the full firehose on the HTC Wire, refreshed automatically every day.